318 related articles for article (PubMed ID: 25985434)
1. Vitamin D in multiple sclerosis and central nervous system demyelinating disease--a review.
Burton JM; Costello FE
J Neuroophthalmol; 2015 Jun; 35(2):194-200. PubMed ID: 25985434
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D as a clinical biomarker in multiple sclerosis.
Carlson NG; Rose JW
Expert Opin Med Diagn; 2013 May; 7(3):231-42. PubMed ID: 23480560
[TBL] [Abstract][Full Text] [Related]
3. High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease.
Häusler D; Torke S; Weber MS
Front Immunol; 2020; 11():301. PubMed ID: 32161591
[TBL] [Abstract][Full Text] [Related]
4. [Chronic inflammatory demyelinating polyradiculoneuropathy associated with central nervous system involvement--as compared to multiple sclerosis].
Komori T; Ohtake T; Miyazaki Y; Hirose K; Tanabe H
Rinsho Shinkeigaku; 1990 Sep; 30(9):939-43. PubMed ID: 2265502
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D in the healthy and inflamed central nervous system: access and function.
Smolders J; Moen SM; Damoiseaux J; Huitinga I; Holmøy T
J Neurol Sci; 2011 Dec; 311(1-2):37-43. PubMed ID: 21862439
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and multiple sclerosis: what is the clinical impact?
Berlanga-Taylor AJ; Ramagopalan SV
Expert Opin Med Diagn; 2013 May; 7(3):227-9. PubMed ID: 23565817
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough.
Häusler D; Weber MS
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626090
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and multiple sclerosis.
Ascherio A; Munger KL; Simon KC
Lancet Neurol; 2010 Jun; 9(6):599-612. PubMed ID: 20494325
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and multiple sclerosis.
Weinstock-Guttman B; Mehta BK; Ramanathan M; Karmon Y; Henson LJ; Halper J; Riskind P
Neurologist; 2012 Jul; 18(4):179-83. PubMed ID: 22735240
[TBL] [Abstract][Full Text] [Related]
10. Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology.
Brum DG; Comini-Frota ER; Vasconcelos CC; Dias-Tosta E
Arq Neuropsiquiatr; 2014 Feb; 72(2):152-6. PubMed ID: 24604370
[TBL] [Abstract][Full Text] [Related]
11. A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.
Miclea A; Bagnoud M; Chan A; Hoepner R
Front Immunol; 2020; 11():781. PubMed ID: 32435244
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin D in Multiple Sclerosis].
Niino M; Miyazaki Y
Brain Nerve; 2015 Nov; 67(11):1429-33. PubMed ID: 26560958
[TBL] [Abstract][Full Text] [Related]
13. [Demyelinating disease affecting both central and peripheral nervous system].
Carra-Dallière C; Mania A; Carlander B; Camu W; Juntas-Morales R
Rev Neurol (Paris); 2011 Dec; 167(12):921-5. PubMed ID: 21596409
[TBL] [Abstract][Full Text] [Related]
14. Patterns and significance of concomitant central and peripheral inflammatory demyelination.
Rezania K; Arnason BG; Soliven B
Neurol Res; 2006 Apr; 28(3):326-33. PubMed ID: 16687061
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of vitamin D binding protein in multiple sclerosis.
Disanto G; Ramagopalan SV; Para AE; Handunnetthi L
J Neurol; 2011 Mar; 258(3):353-8. PubMed ID: 21042807
[TBL] [Abstract][Full Text] [Related]
16. A review of vitamin D supplementation as disease-modifying therapy.
Shoemaker TJ; Mowry EM
Mult Scler; 2018 Jan; 24(1):6-11. PubMed ID: 29307295
[TBL] [Abstract][Full Text] [Related]
17. Review: the role of vitamin D in nervous system health and disease.
DeLuca GC; Kimball SM; Kolasinski J; Ramagopalan SV; Ebers GC
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):458-84. PubMed ID: 23336971
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and multiple sclerosis: where do we go from here?
Salzer J; Biström M; Sundström P
Expert Rev Neurother; 2014 Jan; 14(1):9-18. PubMed ID: 24320602
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
Karussis D
J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system.
Furlan R; Pluchino S; Martino G
Curr Opin Neurol; 2003 Jun; 16(3):385-92. PubMed ID: 12858077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
